Resurgence of


Journal

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
ISSN: 1560-7917
Titre abrégé: Euro Surveill
Pays: Sweden
ID NLM: 100887452

Informations de publication

Date de publication:
Aug 2024
Historique:
medline: 2 8 2024
pubmed: 2 8 2024
entrez: 2 8 2024
Statut: ppublish

Résumé

As other European countries, France is experiencing a resurgence of pertussis in 2024. Between 1 January and 31 May 2024, 5,616 (24.9%) positive

Identifiants

pubmed: 39092529
doi: 10.2807/1560-7917.ES.2024.29.31.2400459
doi:

Substances chimiques

Macrolides 0
Anti-Bacterial Agents 0
pertactin 63GD90PP8X
Bacterial Outer Membrane Proteins 0
Virulence Factors, Bordetella 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Investigateurs

Nathalie Brieu (N)
Jenny Gallou (J)
Audrey Homor (A)
Morgane Choquet (M)
Marie Kempf (M)
Hélène Pailhoriès (H)
Carine Dumollard (C)
Dominique De Briel (D)
Margaux Allain (M)
Guilène Barnaud (G)
Luce Landraud (L)
Julien Bador (J)
Gaëlle Cuzon (G)
Benjamin Aubry (B)
Jean Thomin (J)
Ghislaine Descours (G)
Ani Horikian (A)
Anne-Lise Maucotel (AL)
Hélène Salord (H)
Aubin Souche (A)
Christelle Jost (C)
Frederic Queuche (F)
Agnès Ferroni (A)
Chloé Plouzeau (C)
Stéphane Bland (S)
Hélène Petiprez (H)
Marie Sarah Fangous (MS)
Florence Le Gall (F)
Anne Vachee (A)
Caroline Piau (C)

Auteurs

Carla Rodrigues (C)

These authors contributed equally to this work and share first authorship.
National Reference Center for Whooping Cough and other Bordetella infections, Institut Pasteur, Paris, France.
Institut Pasteur, Université Paris Cité, Biodiversity and Epidemiology of Bacterial Pathogens, Paris, France.

Valérie Bouchez (V)

These authors contributed equally to this work and share first authorship.
National Reference Center for Whooping Cough and other Bordetella infections, Institut Pasteur, Paris, France.
Institut Pasteur, Université Paris Cité, Biodiversity and Epidemiology of Bacterial Pathogens, Paris, France.

Anaïs Soares (A)

Laboratoire Eurofins Biomnis, Lyon, France.

Sabine Trombert-Paolantoni (S)

Laboratoire Cerba, Saint Ouen l'Aumône, France.

Fatima Aït El Belghiti (F)

Santé publique France, Infectious Diseases Department, The French Public Health Agency, Saint-Maurice, France.

Jérémie F Cohen (JF)

Centre for Research in Epidemiology and Statistics (Inserm UMR 1153), Université Paris Cité, Paris, France.
Department of General Paediatrics and Paediatric Infectious Diseases, Université Paris Cité, Hôpital Necker-Enfants Malades, APHP, Paris, France.

Nathalie Armatys (N)

National Reference Center for Whooping Cough and other Bordetella infections, Institut Pasteur, Paris, France.
Institut Pasteur, Université Paris Cité, Biodiversity and Epidemiology of Bacterial Pathogens, Paris, France.

Annie Landier (A)

National Reference Center for Whooping Cough and other Bordetella infections, Institut Pasteur, Paris, France.
Institut Pasteur, Université Paris Cité, Biodiversity and Epidemiology of Bacterial Pathogens, Paris, France.

Thomas Blanchot (T)

Laboratoire Eurofins Biomnis, Lyon, France.

Marie Hervo (M)

Laboratoire Eurofins Biomnis, Lyon, France.
The members of the REMICOQ study group are listed under Collaborators.

Julie Toubiana (J)

These authors co-supervised the work and share last authorship.
Department of General Paediatrics and Paediatric Infectious Diseases, Université Paris Cité, Hôpital Necker-Enfants Malades, APHP, Paris, France.
National Reference Center for Whooping Cough and other Bordetella infections, Institut Pasteur, Paris, France.
Institut Pasteur, Université Paris Cité, Biodiversity and Epidemiology of Bacterial Pathogens, Paris, France.

Sylvain Brisse (S)

These authors co-supervised the work and share last authorship.
National Reference Center for Whooping Cough and other Bordetella infections, Institut Pasteur, Paris, France.
Institut Pasteur, Université Paris Cité, Biodiversity and Epidemiology of Bacterial Pathogens, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH